NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells

Leukemia Research

Volumn 33, Issue 8, 2009, Pages 1108-1113

  Chen, Su ^a   Han, Yu Hui ^a   Zheng, Ying ^a   Zhao, Meng ^b   Yan, Hua ^a   Zhao, Qiao ^a   Chen, Guo Qiang ^a,b   Li, Dao ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

Author keywords

ATRA; C EBP ; Differentiation; Leukemia; NDRG1; PU.1

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN; PROTEIN; RETINOIC ACID; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN U937; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRETINOIN; U937 CELLS; UP-REGULATION;

EID: 67349227483     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.10.016     Document Type: Article

References (34)

1. Shimono A., Okuda T., and Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83 (1999) 39-52
2. Okuda T., and Kondoh H. Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem Biophys Res Commun 266 (1999) 208-215
3. Zhou R.H., Kokame K., Tsukamoto Y., Yutani C., Kato H., and Miyata T. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73 (2001) 86-97
4. Ellen T.P., Ke Q., Zhang P., and Costa M. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29 (2008) 2-8
5. van Belzen N., Dinjens W.N., Diesveld M.P., et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77 (1997) 85-92
6. Ulrix W., Swinnen J.V., Heyns W., and Verhoeven G. The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455 (1999) 23-26
7. Gomez-Casero E., Navarro M., Rodriguez-Puebla M.L., et al. Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis. Mol Carcinog 32 (2001) 100-109
8. Taketomi Y., Sugiki T., Saito T., et al. Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. Biochem Biophys Res Commun 306 (2003) 339-346
9. Taketomi Y., Sunaga K., Tanaka S., et al. Impaired mast cell maturation and degranulation and attenuated allergic responses in Ndrg1-deficient mice. J Immunol 178 (2007) 7042-7053
10. Pabst T., and Mueller B.U. Transcriptional dysregulation during myeloid transformation in AML. Oncogene 26 (2007) 6829-6837
11. Wood B.L. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clin Lab Med 27 (2007) 551-575
12. Fenaux P., Wang Z.Z., and Degos L. Treatment of acute promyelocytic leukemia by retinoids. Curr Top Microbiol Immunol 313 (2007) 101-128
13. Tallman M.S. Acute promyelocytic leukemia as a paradigm for targeted therapy. Semin Hematol 41 (2004) 27-32
14. Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., and Commes T. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim Biophys Acta 1450 (1999) 364-373
15. Huang Y., Du K.M., Xue Z.H., et al. Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1alpha. Leukemia 17 (2003) 2065-2073
16. Stein S., Thomas E.K., Herzog B., et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279 (2004) 48930-48940
17. Zhao K.W., Li X., Zhao Q., et al. Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood 104 (2004) 3731-3738
18. Koschmieder S., Rosenbauer F., Steidl U., Owens B.M., and Tenen D.G. Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukaemia. Int J Hematol 81 (2005) 368-377
19. Rosmarin A.G., Yang Z., and Resendes K.K. Transcriptional regulation in myelopoiesis: hematopoietic fate choice, myeloid differentiation, and leukemogenesis. Exp Hematol 33 (2005) 131-143
20. Duprez E., Wagner K., Koch H., and Tenen D.G. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J 22 (2003) 5806-5816
21. Mueller B.U., Pabst T., Fos J., et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 107 (2006) 3330-3338
22. Liu W., Guo M., Xu Y.B., et al. Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia. Blood 107 (2006) 698-707
23. Song L.P., Zhang J., Wu S.F., et al. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent. Oncogene 27 (2008) 519-527
24. Han Y.H., Xia L., Song L.P., et al. Comparative proteomic analysis of hypoxia-treated and untreated human leukemic U937 cells. Proteomics 6 (2006) 3262-3274
25. DeKoter R.P., Kamath M.B., and Houston I.B. Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models. Blood Cells Mol Dis 39 (2007) 316-320
26. Nerlov C., and Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 12 (1998) 2403-2412
27. Scott E.W., Simon M.C., Anastasi J., Singh H., and Singh. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994) 1573-1577
28. Rosenbauer F., Wagner K., Kutok J.L., et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36 (2004) 624-630
29. Mueller B.U., Pabst T., Osato M., et al. Heterozygous PU.1 mutations are associated with acute myeloid leukaemia. Blood 100 (2002) 998-1007
30. Vangala R.K., Heiss-Neumann M.S., Rangatia J.S., et al. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukaemia. Blood 101 (2003) 270-277
31. Lekstrom-Himes J., and Xanthopoulos K.G. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273 (1998) 28545-28548
32. McKnight S.L. McBindall-a better name for CCAAT/enhancer binding proteins?. Cell 107 (2001) 259-261
33. Yamanaka R., Kim G.D., Radomska H.S., et al. CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 94 (1997) 6462-6467
34. Popernack P.M., Truong L.T., Kamphuis M., and Henderson A.J. Ectopic expression of CCAAT/enhancer binding protein beta (C/EBPbeta) in long-term bone marrow cultures induces granulopoiesis and alters stromal cell function. J Hematother Stem Cell Res 10 (2001) 631-642